Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 21 Carcinoma, Non-Small-Cell Lung 20 Neoplasms 18 Breast Neoplasms 18 Glioblastoma 17 Esophageal Squamous Cell Carcinoma 16 Rectal Neoplasms 15 Lung Neoplasms 15 Esophageal Neoplasms 15 Head and Neck Neoplasms 12 Uterine Cervical Neoplasms 11 Neoplasm Metastasis 10 Glioma 10 Nasopharyngeal Carcinoma 8 Stomach Neoplasms 7 Radiation Injuries 7 Oropharyngeal Neoplasms 7 Brain Neoplasms 7 Hyperthermia 6 Carcinoma, Hepatocellular 6 Astrocytoma 6 Urinary Bladder Neoplasms 5 Small Cell Lung Carcinoma 5 Sarcoma 5 Oligodendroglioma 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4

Interventions

Taxes 1 Standard of Care 1 Radiotherapy 1 Nivolumab 1 Immunotherapy 1 Cisplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Muscle-Invasive Bladder Carcinoma × Radiotherapy × Clear all

NCT05203913 2024-10-04

CNN-BC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Recruiting

Muscle-Invasive Bladder Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡